Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Carlton
Clinical trial register · Australia

Clinical Trials in Carlton, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company4 AbbVie2 Cochlear2 Takeda2 Sanofi2
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Carlton

33 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Eli Lilly and Company
Phase 3
1,000
Brisbane, Bruce, Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
2026-08-14
Recruiting
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
NCT07280065PTSD - Post Traumatic Stress Disorder
Senseye, Inc.
Phase 3
1,900
Carlton
2026-02-23
Recruiting
Eli Lilly and Company
Phase 3
1,000
Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
2026-02-09
Recruiting
Takeda
Phase 2
90
Darlinghurst, Westmead, Carlton, Melbourne
2026-01-26
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
84
Woolloongabba, Carlton
2025-12-01
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Darlinghurst, Kogarah, Westmead, Greenslopes, Woolloongabba, Carlton, Clayton, East Melbourne
2025-09-22
Recruiting
Neurocrine Biosciences
Phase 3
550
Carlton, Melbourne, Parkville
2025-08-18
Recruiting
Bristol-Myers Squibb
Phase 3
586
Kogarah, Macquarie Park, Carlton, Perth, Darlinghurst
2025-07-14
Not yet open
Menicon Co., Ltd.
Not applicable
220
Hillsdale, Sydney, Kelvin Grove, Carlton
2025-07-01
Recruiting
Inmagene LLC
Phase 2
405
Woden, Liverpool, Benowa, Carlton, Mitcham
2025-06-17
Active, closed
Apogee Therapeutics, Inc.
Phase 1
86
Darlinghurst, Kogarah, Westmead, Woolloongabba, Carlton, East Melbourne, Mitcham, Parkville
2025-06-04
Active, closed
An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant Recipients
NCT06867380Cochlear Implant Recipients, Hearing Loss, Cochlear
Cochlear
Not applicable
120
Carlton, East Melbourne
2025-05-27
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Kogarah, Campbelltown, Carlton, East Melbourne
2025-01-08
Recruiting
atai Therapeutics, Inc.
Phase 2
142
Camperdown, Carlton, Melbourne, Northcote, Parkville
2024-12-30
Active, closed
Takeda
Phase 3
2,099
Kogarah, Benowa, Carlton, Parkville
2024-09-04
Recruiting
Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
NCT06412757Post Traumatic Stress Disorder
Deakin University
Phase 3
278
Carlton, Geelong, Heidelberg, Melbourne
2024-08-26
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Carlton, Chermside, Darlinghurst, Ivanhoe, Kogarah, Macquarie Park, Nedlands
2024-07-22
Recruiting
Dose-Response Effects of Mindfulness Meditation
NCT06378450Well-Being, Psychological, Depression
University of Melbourne
Not applicable
860
Carlton
2024-05-01
Recruiting
Sanofi Pasteur, a Sanofi Company
Phase 1/2
800
Phillip, Kotara, Sydney, Waitara, Woolloongabba, Carlton, Melbourne
2024-04-05
Active, closed
Melanoma and Skin Cancer Trials Limited
Phase 3
146
Camperdown, Westmead, Chermside, Woolloongabba, Carlton, Melbourne
2024-02-09
Active, closed
Incyte Corporation
Phase 3
617
Charlestown, Kogarah, Liverpool, Woolloongabba, Carlton, Melbourne
2024-01-30
Active, closed
Pfizer
Phase 3
394
Darlinghurst, Campbelltown, Carlton, East Melbourne, Melbourne
2024-01-19
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Woolloongabba, Carlton, Melbourne
2023-12-07
Recruiting
AbbVie
Phase 3
1,500
Darlinghurst, Kogarah, Coorparoo, Woolloongabba, Carlton, East Melbourne, Parkville, Fremantle
2023-10-11
Active, closed
Cochlear
Not applicable
150
Melbourne E., Sydney, Carlton
2023-09-11
Active, closed
AbbVie
Phase 3
1,328
Phillip, Darlinghurst, Carlton, East Melbourne, Melbourne
2023-06-21
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
DrugDonanemab
Eli Lilly and Company
Phase 3
1,500
Botany, Box Hill, Brisbane, Carlton, Erina, Ivanhoe, Kogarah, Malvern
2022-10-10
Active, closed
Sanofi
Phase 2/3
1,856
Westmead, Greenslopes, Carlton, Melbourne, Parkville, Traralgon
2022-08-22
Active, closed
Kirby Institute
Phase 3
650
Parramatta, Sydney, Southport, Carlton, Melbourne
2021-07-08
Active, closed
Eli Lilly and Company
Phase 3
1,736
Erina, Sydney, Carlton, Glen Iris, Malvern, Melbourne, Parkville
2020-06-19
Active, closed
Galderma R&D
Phase 3
1,700
Darlinghurst, Kogarah, Westmead, Benowa, Brisbane, Woodville, Carlton, East Melbourne
2019-12-30
Active, closed
Sanofi
Observational
955
Kogarah, Woolloongabba, Bedford Park, Carlton
2019-06-11
Active, closed
Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia
NCT02328872Cancer of the Cervix, Cervical Intraepithelial Neoplasia
VCS Foundation
Not applicable
76,181
Carlton
2015-01
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/carlton

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in Carlton.

How many clinical trials are recruiting in Carlton?

14 of the 33 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Carlton), 33 studies
PhaseStudiesRecruitingShare
Phase 319857.6%
Not applicable5115.2%
Phase 24312.1%
Phase 1216.1%
Observational103%
Phase 1/2113%
Phase 2/3103%

Most active sponsors

Lead sponsors with the most studies (Carlton)
Lead sponsorStudiesRecruiting
Eli Lilly and Company42
AbbVie21
Bristol-Myers Squibb22
Cochlear20
Sanofi20
Takeda21
Alumis Inc10
Apogee Therapeutics, Inc.10
atai Therapeutics, Inc.11
Deakin University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.